The anti-tumor effect triggered by ERO1A ablation and aPD-1 treatment was not observed in BALB/c nude mice or anti-CD8 antibody-treated immunocompetent mice (Figures 1H and 1I), suggesting the anti-tumor role of CD8+ T cells in Ero1aKO tumors. The gene discussed is ERO1A; the disease is neoplasm.